Compare Novo Nordisk A/S (NVO) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Zillow Group Inc Class A — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Zillow Group Inc Class A trades at $31.83 (market cap $7.54B). The key difference: Novo Nordisk A/S is far larger — about 29.2× Zillow Group Inc Class A's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Zillow Group Inc Class A pays none. Which is the better fit depends on your goals.
| NVO | ZG | |
|---|---|---|
Market Cap | $220.53B | $7.54B |
Sector | Health | Media |
52-Week High | $71.70 | $86.76 |
52-Week Low | $35.29 | $29.14 |
Enterprise Value | $239.49B | $7.19B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
